unknown
Stage
1
Investors
About
Alchemab develops AI-enabled platforms to discover and advance human-derived antibody therapies for treating diseases.
Explore Alchemab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.